#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	1042	CRP	633	633	99.53	CRP.l15.c4.ctg.1	1250	44.8	0	.	p	.	0	K29T	NONSYN	85	87	AAG	387	389	ACG	53;54;53	A;C;G	52;54;53	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3898	Escherichia_coli_EF_Tu	1185	1164	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.2	1164	151.2	1	SNP	p	L121Q	0	.	.	361	363	CTG	359	361	CTG	156;158;163	C;T;G	156;154;159	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:L121Q:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3898	Escherichia_coli_EF_Tu	1185	1164	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.2	1164	151.2	1	SNP	p	Q125K	0	.	.	373	375	CAG	371	373	CAG	195;196;193	C;A;G	193;191;193	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3898	Escherichia_coli_EF_Tu	1185	1164	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.2	1164	151.2	1	SNP	p	Q125E	0	.	.	373	375	CAG	371	373	CAG	195;196;193	C;A;G	193;191;193	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125E:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3898	Escherichia_coli_EF_Tu	1185	1164	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.2	1164	151.2	1	SNP	p	Q125R	0	.	.	373	375	CAG	371	373	CAG	195;196;193	C;A;G	193;191;193	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125R:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3898	Escherichia_coli_EF_Tu	1185	1164	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.2	1164	151.2	1	SNP	p	Y161N	0	.	.	481	483	TAC	479	481	TAC	185;181;184	T;A;C	184;179;183	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161N:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3898	Escherichia_coli_EF_Tu	1185	1164	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.2	1164	151.2	1	SNP	p	Y161C	0	.	.	481	483	TAC	479	481	TAC	185;181;184	T;A;C	184;179;183	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3898	Escherichia_coli_EF_Tu	1185	1164	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.2	1164	151.2	1	SNP	p	Y161D	0	.	.	481	483	TAC	479	481	TAC	185;181;184	T;A;C	184;179;183	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161D:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3898	Escherichia_coli_EF_Tu	1185	1164	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.2	1164	151.2	1	SNP	p	G317D	0	.	.	949	951	GGC	947	949	GGC	150;152;152	G;G;C	149;150;150	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:G317D:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3898	Escherichia_coli_EF_Tu	1185	1164	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.2	1164	151.2	1	SNP	p	A376V	0	.	.	1126	1128	GCA	1124	1126	GCA	98;99;97	G;C;A	90;91;97	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376V:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3898	Escherichia_coli_EF_Tu	1185	1164	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.2	1164	151.2	1	SNP	p	A376S	0	.	.	1126	1128	GCA	1124	1126	GCA	98;99;97	G;C;A	90;91;97	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376S:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3898	Escherichia_coli_EF_Tu	1185	1164	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.2	1164	151.2	1	SNP	p	E379K	0	.	.	1135	1137	GAA	1133	1135	GAA	94;94;93	G,C;A;A	91,1;93;93	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:E379K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3898	Escherichia_coli_EF_Tu	1185	1164	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.2	1164	151.2	0	HET	.	.	.	C954T	.	954	954	C	952	952	C	144	C,T	75,67	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3898	Escherichia_coli_EF_Tu	1185	1164	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.2	1164	151.2	0	HET	.	.	.	T45C	.	45	45	T	43	43	T	81	T,C	53,26	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3898	Escherichia_coli_EF_Tu	1185	1164	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.2	1164	151.2	0	HET	.	.	.	T135C	.	135	135	T	133	133	T	112	T,C	59,43	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3898	Escherichia_coli_EF_Tu	1185	1164	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.2	1164	151.2	0	HET	.	.	.	C216T	.	216	216	C	214	214	C	170	C,T	100,67	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3898	Escherichia_coli_EF_Tu	1185	71	100.0	Escherichia_coli_EF_Tu.l15.c17.ctg.5	322	14.1	1	SNP	p	A376V	0	.	.	1126	1128	GCA	12	14	GCA	9;9;9	G;C;A	4;4;4	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376V:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3898	Escherichia_coli_EF_Tu	1185	71	100.0	Escherichia_coli_EF_Tu.l15.c17.ctg.5	322	14.1	1	SNP	p	A376S	0	.	.	1126	1128	GCA	12	14	GCA	9;9;9	G;C;A	4;4;4	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376S:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3898	Escherichia_coli_EF_Tu	1185	71	100.0	Escherichia_coli_EF_Tu.l15.c17.ctg.5	322	14.1	1	SNP	p	E379K	0	.	.	1135	1137	GAA	21	23	GAA	9;9;9	G;A;A	5;5;5	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:E379K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	1600	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l6.c30.ctg.1	2039	41.8	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1652	1654	AAA	21;21;20	A;A;A	21;21;20	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	2058	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c30.ctg.1	1988	55.4	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1318	1320	GAA	80;83;82	G;A;A	80;83;82	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	464	H_NS	414	414	99.03	H_NS.l6.c4.ctg.1	1127	22.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	5400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	810	177.0	0	.	n	.	0	A1136G	SNP	1136	1136	A	96	96	G	324	G,T	319,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	5400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	810	177.0	0	.	n	.	0	T1138C	SNP	1138	1138	T	98	98	C	307	C	307	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	5400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	810	177.0	0	.	n	.	0	T1142C	SNP	1142	1142	T	102	102	C	265	C	263	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	5400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	810	177.0	0	.	n	.	0	C1170T	SNP	1170	1170	C	130	130	T	222	T	220	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	5400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	810	177.0	0	.	n	.	0	T1220C	SNP	1220	1220	T	180	180	C	257	C	256	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	5400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	810	177.0	0	.	n	.	0	T1245C	SNP	1245	1245	T	205	205	C	205	C	205	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	5400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	810	177.0	0	.	n	.	0	G1253A	SNP	1253	1253	G	213	213	A	226	A	226	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	5400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	810	177.0	0	.	n	.	0	G1256A	SNP	1256	1256	G	216	216	A	236	A	236	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	5400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	810	177.0	0	.	n	.	0	C1258A	SNP	1258	1258	C	218	218	A	234	A	234	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	5400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	810	177.0	0	.	n	.	0	G1266T	SNP	1266	1266	G	226	226	T	228	T	227	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	5400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	810	177.0	0	.	n	.	0	T1267C	SNP	1267	1267	T	227	227	C	224	C	224	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	5400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	810	177.0	0	.	n	.	0	T1275C	SNP	1275	1275	T	235	235	C	221	C,A	220,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	5400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	810	177.0	0	.	n	.	0	G1276A	SNP	1276	1276	G	236	236	A	222	A	221	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	5400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	810	177.0	0	.	n	.	0	A1281G	SNP	1281	1281	A	241	241	G	214	G	213	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	5400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	810	177.0	0	.	n	.	0	T1283C	SNP	1283	1283	T	243	243	C	223	C	223	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	5400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	810	177.0	0	.	n	.	0	G1288T	SNP	1288	1288	G	248	248	T	236	T	236	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	5400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	810	177.0	0	.	n	.	0	A1296G	SNP	1296	1296	A	256	256	G	294	G,A	293,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	5400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	810	177.0	0	.	n	.	0	T1299G	SNP	1299	1299	T	259	259	G	308	G	307	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	5400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	810	177.0	0	.	n	.	0	A1300T	SNP	1300	1300	A	260	260	T	310	T	308	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	5400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	810	177.0	0	.	n	.	0	C1356T	SNP	1356	1356	C	316	316	T	262	T	261	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	5400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	810	177.0	0	.	n	.	0	A1358G	SNP	1358	1358	A	318	318	G	240	G	240	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	5400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	810	177.0	0	.	n	.	0	T1368C	SNP	1368	1368	T	328	328	C	178	C	177	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	5400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	810	177.0	0	.	n	.	0	G1370A	SNP	1370	1370	G	330	330	A	166	A	166	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	5400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	810	177.0	0	.	n	.	0	C1406.	DEL	1406	1406	C	365	365	C	124	C	124	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	5400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	810	177.0	0	.	n	.	0	.1409C	INS	1409	1409	T	369	369	C	124	C	123	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	5400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	810	177.0	0	.	n	.	0	C1431A	SNP	1431	1431	C	391	391	A	49	A	49	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	5400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	810	177.0	0	.	n	.	0	C1432A	SNP	1432	1432	C	392	392	A	48	A	47	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	5400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	810	177.0	0	.	n	.	0	A1441G	SNP	1441	1441	A	401	401	G	38	G	38	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	5400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	810	177.0	0	.	n	.	0	T1464C	SNP	1464	1464	T	424	424	C	37	C	35	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	5400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	810	177.0	0	.	n	.	0	G1473T	SNP	1473	1473	G	433	433	T	134	T	133	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	5400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	810	177.0	0	.	n	.	0	A1475G	SNP	1475	1475	A	435	435	G	145	G	143	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	5400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	810	177.0	0	.	n	.	0	A1548T	SNP	1548	1548	A	508	508	T	130	T	130	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	5400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	810	177.0	1	SNP	n	C1194G	0	.	.	1194	1194	C	154	154	C	244	C	243	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1494	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1702	46.8	0	.	p	.	0	H2R	NONSYN	4	6	CAT	336	338	CGT	45;45;44	C;G;T	45;43;43	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1494	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1702	46.8	0	.	p	.	0	V30I	NONSYN	88	90	GTC	420	422	ATC	53;52;53	A;T;C	53;52;53	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1494	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1702	46.8	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1179	1181	GGC	64;64;64	G;G;C	64;64;63	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2200	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	2277	51.4	0	.	p	.	0	R8S	NONSYN	22	24	AGA	328	330	AGC	39;38;40	A;G;C	39;38;40	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2200	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	2277	51.4	0	.	p	.	0	I142L	NONSYN	424	426	ATA	730	732	CTA	56;55;54	C;T,A;A	52;53,1;54	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2200	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	2277	51.4	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1249	1251	CAA	81;77;75	C;A;A	81;77;75	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2200	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	2277	51.4	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1348	1350	GGT	69;69;69	G;G;T	69;68;69	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2200	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	2277	51.4	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1918	1920	GTT	35;33;34	G;T;T	35;33;34	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	1000	PmrE	1167	1167	96.83	PmrE.l6.c30.ctg.1	1759	30.4	0	.	p	.	0	A125E	NONSYN	373	375	GCA	675	677	GAA	42;42;41	G;A;A	42;41;41	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	1000	PmrE	1167	1167	96.83	PmrE.l6.c30.ctg.1	1759	30.4	0	.	p	.	0	M185T	NONSYN	553	555	ATG	855	857	ACC	24;24;22	A;C;C	23;24;22	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	1000	PmrE	1167	1167	96.83	PmrE.l6.c30.ctg.1	1759	30.4	0	.	p	.	0	S225T	NONSYN	673	675	TCC	975	977	ACT	31;31;31	A;C;T	31;31;31	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	1000	PmrE	1167	1167	96.83	PmrE.l6.c30.ctg.1	1759	30.4	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1365	1367	ATC	19;20;20	A;T;C	19;20;20	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	1314	PmrF	969	969	99.38	PmrF.l15.c30.ctg.1	1543	45.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	116	TEM_1+	858	349	99.14	TEM_1+.l15.c30.ctg.1	351	6.6	0	.	p	.	0	H162R	NONSYN	484	486	CAT	106	108	CGT	2;2;2	C;G;T	2;2;2	.	TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis;TEM-187
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	116	TEM_1+	858	255	98.43	TEM_1+.l15.c30.ctg.2	255	6.4	0	.	p	.	0	F19L	NONSYN	55	57	TTT	19	21	CTT	11;11;12	C;T;T	7;7;8	.	TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis;TEM-187
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	116	TEM_1+	858	255	98.43	TEM_1+.l15.c30.ctg.2	255	6.4	0	.	p	.	0	V82I	NONSYN	244	246	GTT	208	210	ATT	5;4;4	A;T;T	5;4;4	.	TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis;TEM-187
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	3822	acrD	3114	3114	99.1	acrD.l6.c30.ctg.1	3785	53.9	0	.	p	.	0	T85I	NONSYN	253	255	ACC	587	589	ATC	63;62;61	A;T;C	62;62;61	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	3822	acrD	3114	3114	99.1	acrD.l6.c30.ctg.1	3785	53.9	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2300	2302	AAG	35;36;37	A;A;G	35;36;37	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1522	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1754	46.4	0	.	p	.	0	A22V	NONSYN	64	66	GCC	353	355	GTC	21;23;23	G;T;C	21;23;23	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1522	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1754	46.4	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1094	1096	TGC	56;54;56	T;G;C	56;54;56	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	656	3524	acrF	3105	2598	98.5	acrF.l15.c17.ctg.1	3098	60.3	0	.	p	.	0	S46trunc	TRUNC	136	136	T	372	372	T	33	T	33	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	656	3524	acrF	3105	2598	98.5	acrF.l15.c17.ctg.1	3098	60.3	0	.	p	.	0	G148D	NONSYN	442	444	GGC	678	680	GAC	67;69;68	G;A;C	65;67;65	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	656	3524	acrF	3105	2598	98.5	acrF.l15.c17.ctg.1	3098	60.3	0	.	p	.	0	F240L	NONSYN	718	720	TTT	954	956	TTA	35;34;33	T;T;A	35;34;33	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	656	3524	acrF	3105	2598	98.5	acrF.l15.c17.ctg.1	3098	60.3	0	.	p	.	0	D301N	NONSYN	901	903	GAT	1137	1139	AAT	42;42;43	A;A;T	41;42;42	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	656	3524	acrF	3105	2598	98.5	acrF.l15.c17.ctg.1	3098	60.3	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	1924	1924	T	73	T	73	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	656	3524	acrF	3105	2598	98.5	acrF.l15.c17.ctg.1	3098	60.3	0	HET	.	.	.	G186A	.	186	186	G	422	422	G	81	G,A	70,11	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	992	acrR_2	648	648	99.54	acrR_2.l15.c4.ctg.1	1276	41.4	1	SNP	p	R45C	0	.	.	133	135	CGC	449	451	CGC	77;75;75	C;G;C	77;73;74	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	786	acrS	663	663	98.64	acrS.l15.c30.ctg.1	1179	35.4	0	.	p	.	0	L34F	NONSYN	100	102	CTC	323	325	TTC	39;39;37	T;T;C	39;39;37	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	786	acrS	663	663	98.64	acrS.l15.c30.ctg.1	1179	35.4	0	.	p	.	0	E122G	NONSYN	364	366	GAG	587	589	GGG	51;50;51	G;G;G	51;49;51	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	1082	adiY	762	762	99.61	adiY.l15.c4.ctg.1	1356	42.6	0	.	p	.	0	V136L	NONSYN	406	408	GTT	703	705	CTT	78;81;81	C;T;T	78;81;80	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	3734	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3306	60.4	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2194	2196	GCA	84;83;86	G;C;A	83;83;85	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	3734	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3306	60.4	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2455	2457	ACC	70;70;70	A;C,A;C	69;68,1;69	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	3734	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3306	60.4	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2764	2766	GCC	49;50;51	G;C;C	49;48;51	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	2024	arnA_1	1983	1983	98.24	arnA_1.l15.c30.ctg.1	2598	41.7	0	.	p	.	0	G37A	NONSYN	109	111	GGT	414	416	GCT	17;18;22	G;C;T	17;18;22	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	2024	arnA_1	1983	1983	98.24	arnA_1.l15.c30.ctg.1	2598	41.7	0	.	p	.	0	D77E	NONSYN	229	231	GAT	534	536	GAG	20;21;21	G;A;G	20;21;21	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	2024	arnA_1	1983	1983	98.24	arnA_1.l15.c30.ctg.1	2598	41.7	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	570	572	TGC	24;25;28	T;G;C	24;25;28	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	2024	arnA_1	1983	1983	98.24	arnA_1.l15.c30.ctg.1	2598	41.7	0	.	p	.	0	I150V	NONSYN	448	450	ATT	753	755	GTT	44;44;46	G;T;T	44;44;46	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	2024	arnA_1	1983	1983	98.24	arnA_1.l15.c30.ctg.1	2598	41.7	0	.	p	.	0	R200H	NONSYN	598	600	CGC	903	905	CAC	43;42;43	C;A;C	42;41;43	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	2024	arnA_1	1983	1983	98.24	arnA_1.l15.c30.ctg.1	2598	41.7	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1188	1190	ATG	89;89;88	A;T;G	85;85;84	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	2024	arnA_1	1983	1983	98.24	arnA_1.l15.c30.ctg.1	2598	41.7	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2184	2186	CGC	32;34;30	C;G;C	31;34;30	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	878	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1423	33.1	0	.	p	.	0	S221T	NONSYN	661	663	AGC	966	968	ACC	20;19;19	A;C;C	20;19;18	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	878	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1423	33.1	0	.	p	.	0	P225S	NONSYN	673	675	CCG	978	980	TCG	27;28;31	T;C;G,T	27;28;30,1	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	766	baeR	723	723	97.79	baeR.l15.c30.ctg.1	1321	31.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1360	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1904	38.0	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1329	1331	AAA	18;18;20	A;A;A	13;16;18	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1360	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1904	38.0	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1341	1343	GAG	20;22;22	G;A;G	19;20;21	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1360	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1904	38.0	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1347	1349	CAC	25;26;26	C;A;C	22;24;24	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1360	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1904	38.0	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1401	1403	GAG	25;24;24	G;A;G	25;24;24	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	1886	cpxA	1374	1374	98.91	cpxA.l15.c17.ctg.1	2090	48.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	1160	cpxR	699	699	99.43	cpxR.l15.c30.ctg.1	1382	44.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.;cpxR
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	1232	cysB	975	975	99.28	cysB.l15.c4.ctg.1	1598	41.2	0	.	p	.	0	A146T	NONSYN	436	438	GCT	791	793	ACT	62;62;66	A;C;T	62;61;66	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
dfrA1.3002854.NC_010410.3676915_3677389.140	dfrA1.3002854.NC_010410.3676915_3677389.140	1	0	27	736	dfrA1_1	474	474	100.0	dfrA1_1.l15.c30.ctg.1	1051	37.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	dfrA1 is an integron-encoded dihydrofolate reductase found in Escherichia coli;dfrA1
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	1504	emrA	1173	1173	98.29	emrA.l15.c30.ctg.1	1806	44.4	0	.	p	.	0	I219V	NONSYN	655	657	ATC	979	981	GTC	67;66;66	G;T;C	62;64;65	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	2196	emrB	1539	1539	99.74	emrB.l6.c30.ctg.1	2140	54.7	0	.	p	.	0	E197K	NONSYN	589	591	GAA	936	938	AAA	70;70;73	A;A;A,G	70;69;72,1	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	1340	emrD	1191	1191	98.4	emrD.l6.c4.ctg.1	1886	38.0	0	.	p	.	0	G209S	NONSYN	625	627	GGC	969	971	AGC	54;53;54	A;G;C	54;53;53	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	528	68	emrE_1	333	177	90.4	emrE_1.l6.c30.ctg.1	259	4.8	0	.	p	.	0	I100V	NONSYN	298	300	ATT	142	144	GTC	8;8;7	G;T;C	8;8;7	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	528	68	emrE_1	333	177	90.4	emrE_1.l6.c30.ctg.1	259	4.8	0	.	p	.	0	T108A	NONSYN	322	324	ACA	166	168	GCA	4;4;4	G;C;A	4;4;4	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	1096	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1643	35.4	0	.	p	.	0	K176R	NONSYN	526	528	AAG	794	796	AGG	44;44;44	A;G;G	44;43;44	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	1096	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1643	35.4	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1184	1186	GAC	19;20;20	G;A;C	19;20;20	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	896	emrR	531	531	100.0	emrR.l15.c30.ctg.1	1131	42.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.;emrR
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	1842	emrY	1539	1539	99.81	emrY.l15.c4.ctg.1	2127	46.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	750	evgA	615	615	99.19	evgA.l15.c4.ctg.1	1219	32.9	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	477	479	CTG	38;40;39	C;T;G	38;40;39	.	evgA;EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3524	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4170	45.1	0	.	p	.	0	T38I	NONSYN	112	114	ACA	374	376	ATA	20;20;19	A;T;A	20;20;19	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3524	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4170	45.1	0	.	p	.	0	L42V	NONSYN	124	126	CTA	386	388	GTA	12;14;18	G;T;A	12;14;18	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3524	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4170	45.1	0	.	p	.	0	A93T	NONSYN	277	279	GCG	539	541	ACG	34;34;33	A;C;G	34;34;33	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3524	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4170	45.1	0	.	p	.	0	A114E	NONSYN	340	342	GCA	602	604	GAA	51;54;54	G;A;A	51;54;54	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3524	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4170	45.1	0	.	p	.	0	T127A	NONSYN	379	381	ACT	641	643	GCT	42;42;43	G;C;T	42;42;43	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3524	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4170	45.1	0	.	p	.	0	N133D	NONSYN	397	399	AAT	659	661	GAT	25;26;25	G;A;T	24;25;25	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3524	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4170	45.1	0	.	p	.	0	P162S	NONSYN	484	486	CCA	746	748	TCA	32;32;34	T;C;A	31;32;34	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3524	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4170	45.1	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	875	877	CAG	26;26;26	C;A;G	26;26;26	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3524	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4170	45.1	0	.	p	.	0	I251V	NONSYN	751	753	ATT	1013	1015	GTT	30;29;30	G,T;T;T	29,1;29;30	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3524	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4170	45.1	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1169	1171	GAT	30;28;28	G;A;T	30;28;28	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3524	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4170	45.1	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1337	1339	AAT	20;20;19	A;A;T	20;20;19	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3524	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4170	45.1	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1358	1360	TTA	13;13;13	T;T;A	13;13;13	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3524	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4170	45.1	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1559	1561	AAA	21;21;21	A;A;A	21;21;21	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3524	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4170	45.1	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2294	2296	CAT	61;60;60	C;A;T	61;60;60	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3524	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4170	45.1	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2348	2350	CAT	31;31;30	C;A;T	31;31;30	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3524	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4170	45.1	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2366	2368	AGA	28;29;30	A;G;A	28;29;30	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3524	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4170	45.1	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2381	2383	AAT	36;36;36	A;A;T	36;36;36	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3524	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4170	45.1	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2528	2530	TCC	29;29;31	T;C;C	29;29;31	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3524	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4170	45.1	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2693	2695	ATT	33;33;33	A;T;T	33;33;33	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3524	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4170	45.1	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2714	2716	GAT	38;38;39	G;A;T	37;38;39	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3524	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4170	45.1	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2828	2830	GTT	44;45;45	G;T;T	44;45;45	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3524	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4170	45.1	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3113	3115	CAC	37;37;36	C;A;C	36;37;36	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1206	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1398	46.0	1	SNP	p	P64A	0	.	.	190	192	CCA	473	475	CCA	98;96;95	C;C;A,C	97;96;88,1	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1206	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1398	46.0	1	SNP	p	P64L	0	.	.	190	192	CCA	473	475	CCA	98;96;95	C;C;A,C	97;96;88,1	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1206	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1398	46.0	1	SNP	p	P64R	0	.	.	190	192	CCA	473	475	CCA	98;96;95	C;C;A,C	97;96;88,1	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1206	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1398	46.0	1	SNP	p	P64H	0	.	.	190	192	CCA	473	475	CCA	98;96;95	C;C;A,C	97;96;88,1	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1206	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1398	46.0	1	SNP	p	P64S	0	.	.	190	192	CCA	473	475	CCA	98;96;95	C;C;A,C	97;96;88,1	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	790	gadE	528	528	100.0	gadE.l15.c30.ctg.1	1218	34.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	188	gadW	729	278	95.68	gadW.l6.c4.ctg.1	443	14.8	0	.	p	.	0	S234A	NONSYN	700	702	TCG	249	251	GCG	9;10;10	G;C;G	9;10;10	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	188	gadW	729	344	93.31	gadW.l6.c4.ctg.2	344	9.7	0	.	p	.	0	L46P	NONSYN	136	138	CTG	21	23	CCG	4;4;4	C;C;G	3;3;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	188	gadW	729	344	93.31	gadW.l6.c4.ctg.2	344	9.7	0	.	p	.	0	E54D	NONSYN	160	162	GAA	45	47	GAT	7;9;9	G;A;T	7;9;9	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	188	gadW	729	344	93.31	gadW.l6.c4.ctg.2	344	9.7	0	.	p	.	0	I88M	NONSYN	262	264	ATA	147	149	ATG	5;4;4	A;T;G	5;4;4	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	188	gadW	729	344	93.31	gadW.l6.c4.ctg.2	344	9.7	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	150	152	CCG	4;4;4	C;C;G	4;4;4	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	188	gadW	729	344	93.31	gadW.l6.c4.ctg.2	344	9.7	0	.	p	.	0	D100E	NONSYN	298	300	GAC	183	185	GAA	5;5;5	G;A;A	5;5;5	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	188	gadW	729	344	93.31	gadW.l6.c4.ctg.2	344	9.7	0	.	p	.	0	P101S	NONSYN	301	303	CCC	186	188	TCC	4;3;3	T;C;C	4;3;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	188	gadW	729	344	93.31	gadW.l6.c4.ctg.2	344	9.7	0	.	p	.	0	R102G	NONSYN	304	306	CGG	189	191	GGG	3;3;3	G;G;G	3;3;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	188	gadW	729	344	93.31	gadW.l6.c4.ctg.2	344	9.7	0	.	p	.	0	K110N	NONSYN	328	330	AAA	213	215	AAT	7;7;6	A;A;T	7;7;6	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	792	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1406	30.0	0	.	p	.	0	F53L	NONSYN	157	159	TTC	453	455	TTA	36;37;35	T;T;A	36;37;35	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	792	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1406	30.0	0	.	p	.	0	V79I	NONSYN	235	237	GTT	531	533	ATT	28;28;28	A;T;T	28;28;28	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	792	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1406	30.0	0	.	p	.	0	R246G	NONSYN	736	738	AGA	1032	1034	GGA	31;32;31	G;G;A	31;32;31	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	792	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1406	30.0	0	.	p	.	0	S248P	NONSYN	742	744	TCG	1038	1040	CCG	33;35;34	C;C;G	32;34;33	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3596	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3289	58.5	1	SNP	p	D87Y	1	D87Y	NONSYN	259	261	GAC	593	595	TAC	63;64;63	T;A;C	62;59;63	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3596	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3289	58.5	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2366	2368	GAA	53;53;53	G;A;A	53;52;51	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3596	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3289	58.5	1	SNP	p	S83L	0	.	.	247	249	TCG	581	583	TCG	57;58;57	T;C;G,A	56;57;56,1	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3596	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3289	58.5	1	SNP	p	S83W	0	.	.	247	249	TCG	581	583	TCG	57;58;57	T;C;G,A	56;57;56,1	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3596	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3289	58.5	1	SNP	p	S83I	0	.	.	247	249	TCG	581	583	TCG	57;58;57	T;C;G,A	56;57;56,1	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3084	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2955	55.8	1	SNP	p	R136H	0	.	.	406	408	CGC	629	631	CGC	54;54;54	C;G;C	54;54;54	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3084	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2955	55.8	1	SNP	p	R136G	0	.	.	406	408	CGC	629	631	CGC	54;54;54	C;G;C	54;54;54	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3084	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2955	55.8	1	SNP	p	R136S	0	.	.	406	408	CGC	629	631	CGC	54;54;54	C;G;C	54;54;54	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3084	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2955	55.8	1	SNP	p	R136C	0	.	.	406	408	CGC	629	631	CGC	54;54;54	C;G;C	54;54;54	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3084	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2955	55.8	1	SNP	p	R136E	0	.	.	406	408	CGC	629	631	CGC	54;54;54	C;G;C	54;54;54	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3084	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2955	55.8	1	SNP	p	R136I	0	.	.	406	408	CGC	629	631	CGC	54;54;54	C;G;C	54;54;54	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	3084	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2955	55.8	1	SNP	p	R136L	0	.	.	406	408	CGC	629	631	CGC	54;54;54	C;G;C	54;54;54	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	782	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1229	33.9	0	.	p	.	0	A72P	NONSYN	214	216	GCG	508	510	CCG	48;49;51	C;C;G	48;49;51	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	782	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1229	33.9	0	.	p	.	0	T123A	NONSYN	367	369	ACC	661	663	GCC	46;45;46	G;C;C	46;45;45	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	1398	leuO	945	945	99.26	leuO.l15.c30.ctg.1	1531	48.8	0	.	p	.	0	P9S	NONSYN	25	27	CCA	297	299	TCA	33;34;33	T;C;A	33;33;33	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	598	marA	384	384	99.74	marA.l6.c17.ctg.1	1013	31.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	368	marR	435	435	97.7	marR.l15.c4.ctg.1	873	22.2	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	559	561	AGC	21;20;19	A;G;C	19;20;19	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	368	marR	435	435	97.7	marR.l15.c4.ctg.1	873	22.2	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	661	663	CAT	13;13;13	C;A;T	11;11;13	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	368	marR	435	435	97.7	marR.l15.c4.ctg.1	873	22.2	1	SNP	p	V45E	0	.	.	133	135	GTG	385	387	GTG	57;56;54	G;T;G	57;55;53	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	368	marR	435	435	97.7	marR.l15.c4.ctg.1	873	22.2	1	SNP	p	I49S	0	.	.	145	147	ATC	397	399	ATC	57;57;57	A;T;C	56;56;57	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	368	marR	435	435	97.7	marR.l15.c4.ctg.1	873	22.2	1	SNP	p	A70T	0	.	.	208	210	GCA	460	462	GCA	39;39;39	G;C;A	39;39;38	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	368	marR	435	435	97.7	marR.l15.c4.ctg.1	873	22.2	1	SNP	p	R73C	0	.	.	217	219	CGT	469	471	CGT	39;39;39	C;G;T	39;39;39	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	368	marR	435	435	97.7	marR.l15.c4.ctg.1	873	22.2	1	SNP	p	R73S	0	.	.	217	219	CGT	469	471	CGT	39;39;39	C;G;T	39;39;39	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	368	marR	435	435	97.7	marR.l15.c4.ctg.1	873	22.2	1	SNP	p	R77C	0	.	.	229	231	CGC	481	483	CGC	33;33;32	C;G;C	33;33;32	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	368	marR	435	435	97.7	marR.l15.c4.ctg.1	873	22.2	1	SNP	p	R77L	0	.	.	229	231	CGC	481	483	CGC	33;33;32	C;G;C	33;33;32	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	368	marR	435	435	97.7	marR.l15.c4.ctg.1	873	22.2	1	SNP	p	L78M	0	.	.	232	234	CTG	484	486	CTG	32;31;31	C;T;G	31;31;31	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	368	marR	435	435	97.7	marR.l15.c4.ctg.1	873	22.2	1	SNP	p	R94H	0	.	.	280	282	CGC	532	534	CGC	15;17;17	C;G;C	15;17;17	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	368	marR	435	435	97.7	marR.l15.c4.ctg.1	873	22.2	1	SNP	p	R94S	0	.	.	280	282	CGC	532	534	CGC	15;17;17	C;G;C	15;17;17	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	368	marR	435	435	97.7	marR.l15.c4.ctg.1	873	22.2	1	SNP	p	V96E	0	.	.	286	288	GTA	538	540	GTA	16;16;16	G;T;A	16;16;16	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	1004	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1763	30.4	0	.	p	.	0	S7F	NONSYN	19	21	TCC	229	231	TTC	7;8;8	T;T;C	7;8;7	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	1004	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1763	30.4	0	.	p	.	0	R36I	NONSYN	106	108	AGG	316	318	ATC	25;24;21	A;T;C	25;24;21	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	1004	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1763	30.4	0	.	p	.	0	E42A	NONSYN	124	126	GAA	334	336	GCC	8;8;8	G;C;C	8;8;8	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	1004	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1763	30.4	0	.	p	.	0	N43V	NONSYN	127	129	AAT	337	339	GTG	10;10;10	G;T;G	10;10;10	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	1004	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1763	30.4	0	.	p	.	0	E52D	NONSYN	154	156	GAG	364	366	GAT	13;13;13	G;A;T	13;12;13	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	1004	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1763	30.4	0	.	p	.	0	N59T	NONSYN	175	177	AAC	385	387	ACC	19;19;19	A;C;C	19;19;19	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	1004	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1763	30.4	0	.	p	.	0	I68L	NONSYN	202	204	ATA	412	414	TTA	16;16;17	T;T;A	16;16;16	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	1004	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1763	30.4	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	553	555	CAG	61;61;60	C;A;G	61;61;59	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	1004	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1763	30.4	0	.	p	.	0	D128A	NONSYN	382	384	GAC	592	594	GCC	53;53;54	G;C;C	52;52;54	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	1004	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1763	30.4	0	.	p	.	0	S163A	NONSYN	487	489	TCG	697	699	GCG	33;36;38	G;C;G	33;36;37	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	1004	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1763	30.4	0	.	p	.	0	L231V	NONSYN	691	693	CTT	901	903	GTT	24;24;24	G;T;T	23;23;24	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	1004	mdfA	1233	1233	97.0	mdfA.l6.c30.ctg.1	1763	30.4	0	.	p	.	0	R285fs	FSHIFT	853	853	C	1063	1063	C	39	C	39	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	1060	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1714	33.1	0	.	p	.	0	V12trunc	TRUNC	34	34	G	241	241	G	41	G	41	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	1060	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1714	33.1	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	298	300	CAG	23;23;23	C;A;G	23;22;23	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	1060	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1714	33.1	0	.	p	.	0	T83I	NONSYN	247	249	ACC	448	450	ATC	23;23;21	A;T;C,A	23;22;19,1	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	1060	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1714	33.1	0	.	p	.	0	I99M	NONSYN	295	297	ATA	496	498	ATG	31;31;31	A;T;G	31;30;31	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	1060	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1714	33.1	0	.	p	.	0	A130T	NONSYN	388	390	GCC	589	591	ACC	23;24;23	A;C;C	23;24;23	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	1060	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1714	33.1	0	.	p	.	0	P257T	NONSYN	769	771	CCG	970	972	ACG	36;37;38	A;C;G	36;37;38	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3624	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3636	53.1	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	2070	2072	ACC	60;57;55	A;C;C	60;57;55	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3624	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3636	53.1	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2463	2465	CAA	39;36;36	C;A;A	38;36;35	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3624	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3636	53.1	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2631	2633	ATT	33;33;32	A;T;T	32;33;32	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3624	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3636	53.1	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2715	2717	GTT	51;50;51	G;T;T	51;50;51	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3624	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3636	53.1	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2823	2825	GAG	43;43;42	G;A;G	43;43;41	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3624	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3636	53.1	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	3051	3053	ATG	31;32;33	A;T;G	31;32;32	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3624	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3636	53.1	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3186	3188	GAT	64;65;65	G;A;T	62;63;64	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	3334	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3596	49.3	0	.	p	.	0	I46M	NONSYN	136	138	ATC	394	396	ATG	24;26;28	A;T;G	22;25;27	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	3334	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3596	49.3	0	.	p	.	0	V208I	NONSYN	622	624	GTC	880	882	ATC	61;59;58	A,C;T;C	58,1;59;57	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	3334	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3596	49.3	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3196	3198	CAC	11;11;9	C;A;C	11;11;9	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	3334	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3596	49.3	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	3199	3201	CTC	9;8;9	C;T;C	9;8;9	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1716	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	2008	45.8	0	.	p	.	0	D3E	NONSYN	7	9	GAT	283	285	GAA	36;37;37	G;A;A	36;37;37	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1716	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	2008	45.8	0	.	p	.	0	T226A	NONSYN	676	678	ACG	952	954	GCG	44;44;47	G;C;G	44;43;47	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1716	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	2008	45.8	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1294	1296	ATC	65;65;65	A;T;C	62;65;64	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1716	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	2008	45.8	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1597	1599	TTT	56;56;56	T;T;T	56;56;56	.	Efflux pump mdtD;mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	1654	mdtE	1158	1158	99.31	mdtE.l15.c30.ctg.1	1779	49.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	4118	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3686	59.5	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1149	1151	ACC	37;36;36	A;C;C	37;31;36	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	4118	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3686	59.5	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2391	2393	GAC	69;71;73	G;A,G;C	67;69,1;72	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1578	mdtG	1227	1047	99.33	mdtG.l15.c30.ctg.1	1649	42.7	0	.	p	.	0	V200I	NONSYN	598	600	GTC	680	682	ATC	54;54;57	A;T;C	54;54;57	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1578	mdtG	1227	182	99.45	mdtG.l15.c30.ctg.3	447	22.8	0	.	p	.	0	E5G	NONSYN	13	15	GAA	268	270	GGA	12;12;12	G;G;A	12;12;12	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1254	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1694	39.6	0	.	p	.	0	G134C	NONSYN	400	402	GGT	648	650	TGT	52;57;57	T;G;T,C	52;57;56,1	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1254	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1694	39.6	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1218	1220	TTG	36;36;37	T;T;G	36;36;37	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1254	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1694	39.6	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1428	1430	ACG	21;22;22	A;C;G	21;22;22	.	mdtH;Multidrug resistance protein MdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	1546	mdtL	1176	1176	98.38	mdtL.l15.c30.ctg.1	1854	44.7	0	.	p	.	0	A185S	NONSYN	553	555	GCC	843	845	TCC	42;42;42	T;C;C	38;42;42	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	1278	mdtN	1032	1032	98.02	mdtN.l6.c4.ctg.1	1606	42.6	0	.	p	.	0	V119I	NONSYN	355	357	GTT	638	640	ATT	53;53;54	A;T;T	53;53;53	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2530	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2553	52.9	0	.	p	.	0	V11M	NONSYN	31	33	GTG	231	233	ATG	30;31;32	A;T;G	30;31;32	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2530	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2553	52.9	0	.	p	.	0	T33I	NONSYN	97	99	ACC	297	299	ATC	36;37;37	A;T;C	36;36;37	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2530	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2553	52.9	0	.	p	.	0	C116R	NONSYN	346	348	TGC	546	548	CGC	45;46;47	C;G;C	45;46;46	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2530	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2553	52.9	0	.	p	.	0	N238S	NONSYN	712	714	AAC	912	914	AGC	45;46;46	A;G;C	45;45;46	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2530	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2553	52.9	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1113	1115	GTG	43;42;42	G;T;G	42;39;41	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2530	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2553	52.9	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1176	1178	AAC	33;32;31	A;A;C	31;29;28	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2530	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2553	52.9	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1221	1223	GTC	48;47;47	G,T;T;C	46,1;46;47	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2530	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2553	52.9	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1251	1253	ATA	80;79;79	A;T;A	79;78;77	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2530	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2553	52.9	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1359	1361	TCT	44;45;47	T;C;T	44;45;46	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2530	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2553	52.9	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1746	1748	GCG	51;52;53	G;C;G	50;51;53	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2530	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2553	52.9	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1959	1961	ATC	66;68;67	A;T;C	65;68;67	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1478	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	2082	37.9	0	.	p	.	0	S129A	NONSYN	385	387	TCA	654	656	GCG	43;43;46	G;C,G;G	41;39,1;44	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1478	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	2082	37.9	0	.	p	.	0	A187T	NONSYN	559	561	GCC	828	830	ACC	55;55;53	A;C;C	55;55;53	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1478	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	2082	37.9	0	.	p	.	0	H211R	NONSYN	631	633	CAC	900	902	CGC	49;48;48	C;G;C	49;48;47	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1478	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	2082	37.9	0	.	p	.	0	V250A	NONSYN	748	750	GTT	1017	1019	GCT	44;44;45	G;C;T	43;44;44	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1478	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	2082	37.9	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1101	1103	AAA	31;29;26	A;A;A	31;29;26	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1478	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	2082	37.9	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1119	1121	CGA	29;29;30	C;G;A	29;29;30	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1478	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	2082	37.9	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1284	1286	GCC	32;34;33	G;C;C	32;34;33	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1478	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	2082	37.9	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1296	1298	GAT	33;35;36	G;A;T	33;35;36	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1478	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	2082	37.9	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1713	1715	GCT	28;26;27	G;C;T	28;26;27	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	4278	mfd	3447	3447	99.16	mfd.l6.c17.ctg.1	4009	56.7	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1572	1574	AAG	62;62;64	A;A;G	62;61;64	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	4278	mfd	3447	3447	99.16	mfd.l6.c17.ctg.1	4009	56.7	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2649	2651	CTG	55;55;55	C;T;G	53;54;54	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	286	mgrB	144	144	100.0	mgrB.l15.c17.ctg.3	168	46.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	2574	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2333	59.0	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1143	1145	AAC	56;57;59	A;A;C	56;57;59	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	2574	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2333	59.0	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1689	1691	ATA	69;68;69	A;T;A	69;68;68	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1784	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1844	51.6	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1420	1422	GAT	76;78;74	G;A;T	76;76;72	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1784	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1844	51.6	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1423	1425	CTG	73;72;72	C;T;G	72;71;72	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	1024	nfsA	723	379	98.94	nfsA.l15.c4.ctg.1	1004	29.2	0	.	p	.	0	R27C	NONSYN	79	81	CGT	405	407	TGT	39;36;37	T;G;T	39;36;37	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	1024	nfsA	723	379	98.94	nfsA.l15.c4.ctg.1	1004	29.2	0	.	p	.	0	I117T	NONSYN	349	351	ATC	675	677	ACC	50;47;44	A;C;C	48;47;44	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	1024	nfsA	723	379	98.94	nfsA.l15.c4.ctg.1	1004	29.2	1	SNP	p	R15C	0	.	.	43	45	CGC	369	371	CGC	60;57;58	C;G;C	60;57;58	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	1024	nfsA	723	379	98.94	nfsA.l15.c4.ctg.1	1004	29.2	1	SNP	p	S33R	0	.	.	97	99	AGC	423	425	AGC	45;45;44	A;G;C	44;44;44	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	1024	nfsA	723	353	99.15	nfsA.l15.c4.ctg.2	1053	23.8	0	.	p	.	0	G187D	NONSYN	559	561	GGC	512	514	GAC	48;47;46	G;A;C	48;47;46	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	1024	nfsA	723	353	99.15	nfsA.l15.c4.ctg.2	1053	23.8	1	SNP	p	G131D	0	.	.	391	393	GGC	344	346	GGC	43;44;45	G;G;C	43;43;43	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	1024	nfsA	723	353	99.15	nfsA.l15.c4.ctg.2	1053	23.8	1	SNP	p	R203L	0	.	.	607	609	CGT	560	562	CGT	60;59;61	C;G;T	60;59;61	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	1024	nfsA	723	353	99.15	nfsA.l15.c4.ctg.2	1053	23.8	1	SNP	p	R203C	0	.	.	607	609	CGT	560	562	CGT	60;59;61	C;G;T	60;59;61	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1794	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1701	56.1	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1246	1248	GAG	69;65;69	G;A;G	69;65;69	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1794	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1701	56.1	1	SNP	p	G141E	0	.	.	421	423	GGT	733	735	GGT	87;86;84	G;G;T	87;85;82	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1794	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1701	56.1	1	SNP	p	G141D	0	.	.	421	423	GGT	733	735	GGT	87;86;84	G;G;T	87;85;82	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1794	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1701	56.1	1	SNP	p	R154D	0	.	.	460	462	CGT	772	774	CGT	88;87;87	C;G;T	87;87;87	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1794	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1701	56.1	1	SNP	p	R154A	0	.	.	460	462	CGT	772	774	CGT	88;87;87	C;G;T	87;87;87	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3336	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2885	61.7	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1949	1951	GTG	93;92;93	G;T;G	93;92;92	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3336	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2885	61.7	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1976	1978	TCG	65;65;66	T;C;G	54;59;64	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3336	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2885	61.7	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2591	2593	AAC	44;43;43	A;A;C	44;43;42	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3336	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2885	61.7	1	SNP	p	A85T	0	.	.	253	255	GCG	605	607	GCG	63;65;63	G;C;G	60;61;60	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3336	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2885	61.7	1	SNP	p	D111H	0	.	.	331	333	GAT	683	685	GAT	66;69;68	G;A;T	66;69;68	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	3336	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2885	61.7	1	SNP	p	S129P	0	.	.	385	387	TCC	737	739	TCC	75;72;74	T;C;C	74;72;74	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	2076	parE_1	1893	1893	97.52	parE_1.l15.c4.ctg.1	2562	43.3	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1720	1722	AAC	65;65;65	A;A;C	65;65;64	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	2076	parE_1	1893	1893	97.52	parE_1.l15.c4.ctg.1	2562	43.3	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1729	1731	GAT	67;66;67	G;A;T	67;65;67	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1960	patA	1380	1380	99.78	patA.l15.c4.ctg.1	2030	51.7	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	906	908	CAG	66;66;67	C,G;A;G	64,1;64;67	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1960	patA	1380	1380	99.78	patA.l15.c4.ctg.1	2030	51.7	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1380	1382	GAT	67;69;71	G;A;T	67;68;71	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6004	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4600	69.5	1	SNP	p	V146F	0	.	.	436	438	GTT	692	694	GTT	77;77;78	G;T;T	77;77;78	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6004	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4600	69.5	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1793	1795	CAG	81;81;82	C;A;G	80;81;82	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6004	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4600	69.5	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1793	1795	CAG	81;81;82	C;A;G	80;81;82	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6004	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4600	69.5	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1832	1834	CAC	73;73;74	C;A;C	73;70;74	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6004	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4600	69.5	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1841	1843	CGT	68;65;63	C;G;T	67;64;61	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6004	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4600	69.5	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1841	1843	CGT	68;65;63	C;G;T	67;64;61	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6004	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4600	69.5	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1847	1849	TCC	63;62;61	T;C;C	63;61;60	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6004	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4600	69.5	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1853	1855	CTC	59;58;60	C;T;C	59;58;59	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6004	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4600	69.5	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1943	1945	ACC	71;72;72	A;C;C	71;72;72	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6004	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4600	69.5	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1946	1948	CCT	72;71;66	C;C;T	72;71;66	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	6004	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4600	69.5	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2315	2317	CGT	87;87;85	C;G;T	87;86;85	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	16360	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1930	434.7	0	.	n	.	0	A226G	SNP	226	226	A	343	343	G	598	G	598	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	16360	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1930	434.7	1	SNP	n	A794G	0	.	.	794	794	A	911	911	A	449	A	440	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	16360	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1930	434.7	1	SNP	n	A794T	0	.	.	794	794	A	911	911	A	449	A	440	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	16360	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1930	434.7	1	SNP	n	G926A	0	.	.	926	926	G	1043	1043	G	443	G,A	440,2	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	16360	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1930	434.7	1	SNP	n	G926T	0	.	.	926	926	G	1043	1043	G	443	G,A	440,2	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	16360	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1930	434.7	1	SNP	n	G926C	0	.	.	926	926	G	1043	1043	G	443	G,A	440,2	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	16360	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1930	434.7	1	SNP	n	A1519C	0	.	.	1519	1519	A	1636	1636	A	454	A,G	447,2	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	16360	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1930	434.7	1	SNP	n	A1519T	0	.	.	1519	1519	A	1636	1636	A	454	A,G	447,2	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	16360	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1930	434.7	1	SNP	n	A1519G	0	.	.	1519	1519	A	1636	1636	A	454	A,G	447,2	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	16360	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1930	434.7	0	HET	.	.	.	G1006C	.	1006	1006	G	1123	1123	G	517	G,C	321,186	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	16360	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1930	434.7	0	HET	.	.	.	A79G	.	79	79	A	196	196	A	421	A,G	304,110	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	16360	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1930	434.7	0	HET	.	.	.	C719T	.	719	719	C	836	836	C	436	C,T	255,180	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	16360	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1930	434.7	0	HET	.	.	.	T273A	.	273	273	T	390	390	T	501	T,A	362,130	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	16360	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1930	434.7	0	HET	.	.	.	T1010C	.	1010	1010	T	1127	1127	T	512	T,C	315,185	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	16360	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1930	434.7	0	HET	.	.	.	C1038T	.	1038	1038	C	1155	1155	C	484	C,T	295,186	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	16360	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1930	434.7	0	HET	.	.	.	C183T	.	183	183	C	300	300	C	451	C,T	328,116	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	16360	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1930	434.7	0	HET	.	.	.	A250T	.	250	250	A	367	367	A	536	A,T	402,132	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	16360	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1930	434.7	0	HET	.	.	.	T90C	.	90	90	T	207	207	T	417	T,C	304,106	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	16360	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1930	434.7	0	HET	.	.	.	G474A	.	474	474	G	591	591	G	536	G,A	400,130	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	16360	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1930	434.7	0	HET	.	.	.	A253T	.	253	253	A	370	370	A	528	A,T	393,132	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	16360	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1930	434.7	0	HET	.	.	.	C194T	.	194	194	C	311	311	C	497	C,T	417,77	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	16360	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1930	434.7	0	HET	.	.	.	G1002A,C	.	1002	1002	G	1119	1119	G	507	G,A,C	321,185,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
sat_1.3002895.AB211124.0_525.584	sat_1.3002895.AB211124.0_525.584	1	0	27	1006	sat_1	525	525	100.0	sat_1.l15.c30.ctg.1	1075	49.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sat-1 is a plasmid-mediated streptothricin acetyltransferase in Escherichia coli;sat-1
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	838	soxR	465	465	100.0	soxR.l6.c4.ctg.1	1056	42.4	1	SNP	p	R20H	0	.	.	58	60	CGC	388	390	CGC	70;73;73	C;G;C	68;73;73	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	838	soxR	465	465	100.0	soxR.l6.c4.ctg.1	1056	42.4	1	SNP	p	G121D	0	.	.	361	363	GGT	691	693	GGT	71;71;71	G;G;T	71;71;71	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	536	soxS_1	324	324	99.69	soxS_1.l15.c4.ctg.1	879	32.5	1	SNP	p	A12S	0	.	.	34	36	GCA	299	301	GCA	54;54;55	G;C;A	53;53;54	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
strA.manually_added_NC_009345_WP_001082319.1_6656_7459	strA.manually_added_NC_009345_WP_001082319.1_6656_7459	1	0	539	6174	APH_3____Ib+	804	804	99.88	APH_3____Ib+.l15.c4.ctg.1	1471	223.6	0	.	p	.	0	P121Q	NONSYN	361	363	CCG	685	687	CAG	353;353;351	C;A;G	350;349;348	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
strB.manually_added_NC_009345_WP_000480968.1_7459_8295	strB.manually_added_NC_009345_WP_000480968.1_7459_8295	1	0	27	6406	APH_6__Id+	837	837	100.0	APH_6__Id+.l6.c30.ctg.1	1378	247.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
sul2.3000412.AY055428.20268_21084.552	sul2.3000412.AY055428.20268_21084.552	1	0	27	4572	sul2	816	816	100.0	sul2.l15.c4.ctg.1	1394	174.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sul2;Sul2 is a sulfonamide resistant dihydropteroate synthase of Gram-negative bacteria, usually found on small plasmids.
tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	1	0	27	6696	tetA	1200	1200	100.0	tetA.l6.c4.ctg.1	1853	192.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetR.manually_added_NC_009345_WP_000164043.1_474_1124	tetR.manually_added_NC_009345_WP_000164043.1_474_1124	1	0	27	4296	tetR	651	651	100.0	tetR.l15.c4.ctg.1	1290	177.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	2130	tolC	1488	1488	98.72	tolC.l15.c4.ctg.1	2168	52.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
